Preventive Cardiology

Resource Center

Commentary

new medications

Is It Finally Time to Consider a Polypill Approach to Cardiovascular Disease Risk Reduction?

03/08/2015

In this article Michael J. Bloch, MD, writes about the potential use of a polypill for cardiovascular disease prevention and discusses how the results of recent research supports the potential use in the...

03/08/2015

Research Summaries

research summary

CVD Risk Is Increased in Patients with HIV and NAFLD, Liver Fibrosis

04/26/2023

Leigh Precopio

To better understand the relationship between cardiovascular disease and liver disease in individuals with HIV, researchers examined both traditional risk factors and HIV-specific risk factors of the...

04/26/2023

treatment

Apixaban Lowers GI Bleeding Risk in Patients With Atrial Fibrillation

11/04/2022

In a recent study, researchers examined the efficacy and impact of various direct oral anticoagulants on multiple health outcomes in individuals with atrial fibrillation.

11/04/2022

nutrition

USPSTF Updates Recommendation on Supplements for CVD, Cancer

07/05/2022

The USPSTF has updated its recommendations on the use of vitamins and dietary supplements for the prevention of cardiovascular disease or cancer.

07/05/2022

diabetes risk

Arterial Stiffness, Hypertension for Predicting Diabetes Risk

06/01/2022

Researchers compared the effectiveness of using arterial stiffness vs hypertension in predicting the risk of type 2 diabetes.

06/01/2022

diagnosis and management

AHA Releases First Scientific Statement on NAFLD, ASCVD

04/28/2022

Nonalcoholic fatty liver disease is estimated to occur in 1 in 4 adults worldwide but understanding of the disease and associated complications is lacking. The American Heart Association recently released a...

04/28/2022

April 2024

Current Issue

April 2024

Volume 64

Issue 4